Tevogen Bio Holdings INC Form 4 insider transactions

Victor J. Sordillo, a director at Tevogen Bio Holdings, received 240,000 restricted stock units that vested immediately and another 240,000 that will vest over four years.

Director Goh Keow Lin of Tevogen Bio Holdings Inc. was granted 240,000 restricted stock units (RSUs) that will vest over four years.

Neal Flomenberg, Chief Scientific Officer of Tevogen Bio Holdings, sold shares to cover tax obligations related to vesting of restricted stock units.

Kirti Desai, CFO of Tevogen Bio Holdings Inc., recently purchased 3,000 shares of common stock at $0.82 per share, increasing his total holdings to 9,699,186 shares.

CEO Ryan H. Saadi reports purchasing additional shares of Tevogen Bio Holdings, increasing his direct holdings.